药店跨界卖宠物用品？中国宠物经济爆发下的行业争议
中国宠物市场迎来爆发式增长
China's Pet Market Experiences Explosive Growth
根据高盛资本最新报告显示，2024年中国宠物数量将首次超过4岁以下儿童。到2030年，中国城镇宠物数量预计突破7000万只，达到幼儿数量的2倍。
According to the latest report from Goldman Sachs, China's pet population will surpass the number of children under 4 for the first time in 2024. By 2030, urban pets in China are projected to exceed 70 million, doubling the number of young children.
惊人的市场数据
Staggering Market Statistics
2023年中国宠物经济规模已达5928亿元，预计到2028年将突破1.15万亿元人民币。
China's pet economy reached 592.8 billion yuan in 2023, and is expected to exceed 1.15 trillion yuan by 2028.
药店行业跨界新趋势
Pharmacy Industry's New Cross-border Trend
包括益丰、老百姓、漱玉平民等六大上市连锁药店，以及国药控股、海王星辰等大型连锁企业均已开始试点经营宠物用品。
Six listed pharmacy chains including Yifeng, Lao Bai Xing, and Shuyu Pingmin, as well as major players like Sinopharm Holding and Neptune Galaxy have all begun pilot programs for pet supplies.
行业争议持续发酵
Growing Industry Controversy
尽管在法律层面没有禁售规定，但将人用药品与宠物用品混售的做法引发了行业专家的强烈质疑。
While there are no legal prohibitions, the practice of mixing human medications with pet supplies has drawn strong criticism from industry experts.
专家观点
Expert Opinion
"作为行业领导者，应该坚守'为了人类健康'的使命，而不是变成'为了人和动物的健康'"
"As industry leaders, they should adhere to the mission of 'for human health', rather than changing to 'for human and animal health'"
未来展望
Future Outlook
在医保政策收紧的背景下，药店多元化发展成为必然选择，但选择何种多元化路径仍需审慎考量。
With tightening medical insurance policies, diversification is inevitable for pharmacies, but the choice of diversification path still requires careful consideration.
